A detailed history of Caprock Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Caprock Group, Inc. holds 61,252 shares of NVO stock, worth $6.44 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
61,252
Holding current value
$6.44 Million
% of portfolio
0.27%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$119.07 - $145.42 $7.29 Million - $8.91 Million
61,252 New
61,252 $7.29 Million
Q1 2024

Apr 29, 2024

SELL
$102.11 - $135.92 $347,378 - $462,399
-3,402 Reduced 10.76%
28,215 $3.62 Million
Q4 2023

Jan 18, 2024

SELL
$87.78 - $105.45 $242,448 - $291,252
-2,762 Reduced 8.03%
31,617 $3.27 Million
Q3 2023

Oct 18, 2023

BUY
$90.94 - $199.54 $1.61 Million - $3.52 Million
17,663 Added 105.67%
34,379 $3.13 Million
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $70,035 - $77,519
449 Added 2.76%
16,716 $2.71 Million
Q1 2023

Apr 26, 2023

SELL
$132.34 - $159.14 $170,453 - $204,972
-1,288 Reduced 7.34%
16,267 $2.59 Million
Q4 2022

Jan 23, 2023

BUY
$102.55 - $135.33 $26,663 - $35,185
260 Added 1.5%
17,555 $0
Q3 2022

Nov 07, 2022

BUY
$95.28 - $116.93 $93,183 - $114,357
978 Added 5.99%
17,295 $1.72 Million
Q2 2022

Jul 26, 2022

SELL
$103.24 - $121.81 $53,994 - $63,706
-523 Reduced 3.11%
16,317 $1.82 Million
Q1 2022

Apr 12, 2022

SELL
$93.1 - $112.54 $37,612 - $45,466
-404 Reduced 2.34%
16,840 $1.89 Million
Q4 2021

Jan 18, 2022

SELL
$95.88 - $117.08 $41,036 - $50,110
-428 Reduced 2.42%
17,244 $1.93 Million
Q3 2021

Oct 07, 2021

SELL
$84.42 - $106.62 $413,826 - $522,651
-4,902 Reduced 21.72%
17,672 $1.7 Million
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $21,651 - $27,123
-320 Reduced 1.4%
22,574 $1.89 Million
Q1 2021

Apr 29, 2021

BUY
$67.06 - $75.82 $53,513 - $60,504
798 Added 3.61%
22,894 $1.57 Million
Q4 2020

Jan 29, 2021

BUY
$63.89 - $73.8 $4,280 - $4,944
67 Added 0.3%
22,096 $1.54 Million
Q3 2020

Oct 29, 2020

BUY
$63.69 - $70.22 $10,381 - $11,445
163 Added 0.75%
22,029 $1.53 Million
Q2 2020

Aug 05, 2020

SELL
$58.54 - $67.94 $209,221 - $242,817
-3,574 Reduced 14.05%
21,866 $1.43 Million
Q1 2020

Apr 28, 2020

BUY
$49.46 - $64.78 $65,682 - $86,027
1,328 Added 5.51%
25,440 $1.55 Million
Q4 2019

Feb 04, 2020

SELL
$49.86 - $58.26 $3,739 - $4,369
-75 Reduced 0.31%
24,112 $1.4 Million
Q3 2019

Oct 31, 2019

SELL
$47.54 - $53.43 $32,707 - $36,759
-688 Reduced 2.77%
24,187 $1.25 Million
Q2 2019

Jul 23, 2019

BUY
$46.79 - $52.47 $3,322 - $3,725
71 Added 0.29%
24,875 $1.27 Million
Q1 2019

Apr 12, 2019

BUY
$46.36 - $52.63 $4,775 - $5,420
103 Added 0.42%
24,804 $1.32 Million
Q4 2018

Jan 29, 2019

BUY
$41.54 - $47.25 $46,067 - $52,400
1,109 Added 4.7%
24,701 $1.14 Million
Q2 2018

Jul 23, 2018

BUY
$44.29 - $50.42 $21,037 - $23,949
475 Added 2.05%
23,592 $1.09 Million
Q1 2018

Apr 23, 2018

BUY
$48.49 - $58.14 $8,922 - $10,697
184 Added 0.8%
23,117 $1.16 Million
Q4 2017

Jan 17, 2018

BUY
$47.53 - $53.73 $1,758 - $1,988
37 Added 0.16%
22,933 $1.26 Million
Q3 2017

Oct 23, 2017

BUY
$41.15 - $49.22 $942,170 - $1.13 Million
22,896
22,896 $1.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.